15 November 2024
The Chairman of the Egypt Healthcare Authority meets with the General Manager of Takeda Egypt

The Chairman of the Egypt Healthcare Authority meets with the General Manager of Takeda Egypt and representatives of the National Health Service (NHS) to discuss ways to enhance joint cooperation for the benefit of cancer patients.

Chairman of the Egypt Healthcare Authority: An Egyptian-British collaboration to establish the first cancer center of excellence with shared expertise from the Christie Foundation, the first and largest cancer treatment institution in the UK.

Chairman of the Egypt Healthcare Authority: Agreement reached to launch a comprehensive cancer care center in Ismailia as the first phase, with plans to expand the project to Upper Egypt in the second phase.

Chairman of the Egypt Healthcare Authority: Agreement to operate a comprehensive cancer care center in the Ismailia Medical Complex in partnership with the Christie Foundation to transfer global expertise and make a significant leap in cancer treatment services in Egypt, and to collaborate in the field of cancer treatment and research.

Chairman of the Egypt Healthcare Authority: The collaboration will include training medical staff at the Ismailia Medical Complex with the participation of 14 experts from England on diagnostics and the latest treatments for cancer patients, followed by sending Egyptian doctors for training in NHS institutions in the UK.

General Manager of Takeda Egypt: We are proud of our collaboration with the Egypt Healthcare Authority and believe in strengthening partnerships between the public and private sectors for comprehensive development. He emphasizes the importance of clinical research to develop innovative cancer treatments for Egyptian patients.

Representatives of the National Health Service (NHS): What we saw during our visit to the Ismailia Medical Complex of the Egypt Healthcare Authority confirms a significant shift in healthcare services in Egypt. They praised the dedication of medical and administrative staff, the quality of care, and the electronic system, affirming that the collaboration with the Egypt Healthcare Authority will yield great successes in the future.


Dr. Ahmed El-Sebki, Chairman of the Egypt Healthcare Authority and General Supervisor of the Universal Health Insurance Project, met with Dr. Sami Khalil, General Manager of Takeda Egypt, and several representatives from the National Health Service (NHS), including Dr. Rachel Chun, Director of Research, Innovation, and Training at the Christie Foundation (part of NHS), Professor Sarah Oduyer, Consultant Surgeon and Head of the Peritoneal Cancer Clinic, and Professor Mark Saunders, Consultant Clinical Oncologist, at the authority's headquarters in the New Administrative Capital.

At the beginning of the meeting, Dr. Ahmed El-Sebki welcomed the attendees and emphasized the importance of joint cooperation in developing Egypt’s healthcare system. He noted that the collaboration with the NHS will involve establishing the first cancer center of excellence with shared expertise from the Christie Foundation, the largest and first cancer treatment institution in the UK.

Dr. El-Sebki added that an agreement has been reached to launch a comprehensive cancer care center in Ismailia as the first phase, with plans to expand the project to Upper Egypt in the second phase.

He clarified that an agreement has been made to operate the comprehensive cancer care center in the Ismailia Medical Complex in partnership with the Christie Foundation to transfer global expertise and make a significant shift in cancer treatment services in Egypt, along with collaborating in cancer treatment and research.

Dr. El-Sebki emphasized that the cooperation will include training medical staff at the Ismailia Medical Complex with 14 experts from England on diagnostics and the latest treatments for cancer patients. Additionally, Egyptian doctors will be sent for training in NHS institutions in the UK.

Dr. Sami Khalil, General Manager of Takeda Egypt, expressed his happiness with the meeting and said, "We are proud of our collaboration with the Egypt Healthcare Authority, and we believe in strengthening partnerships between the public and private sectors for comprehensive development." He stressed the importance of clinical research in developing modern and innovative cancer treatments for Egyptian patients.

Representatives from the NHS expressed their great satisfaction with the meeting, confirming that what they saw during their visit to the Ismailia Medical Complex reflects a significant shift in healthcare services in Egypt. They praised the dedication of the medical and administrative staff, the quality of care, and the electronic system, affirming that collaboration with the Egypt Healthcare Authority will lead to great future successes.

The meeting was attended by several leaders from the Egypt Healthcare Authority, including Dr. Ahmed Hamad, the Advisor to the Chairman of the Authority for Health Policies and Systems and General Director of the Technical Office of the Chairman, Dr. Sherif Kamal, the Authority's Advisor for Pharmaceutical Affairs and Drug Management, and Dr. Radwa Abdel-Azim, Head of the Oncology Department in the Chairman’s Technical Office.

It is worth noting that the NHS representatives visited the Ismailia Medical Complex, where the visit included a tour of various departments, including clinics, the Daycare Chemotherapy Unit, radiology departments, labs, and pharmacies.

The visit also included a presentation explaining the development of the healthcare system in Egypt and the services offered by the Egypt Healthcare Authority, including the use of the latest medical and non-medical technologies, service digitization, unification and standardization of clinical protocols, training and qualification of human resources, obtaining national and international accreditations, and improving the satisfaction of beneficiaries, among other remarkable developments.

The NHS representatives also delivered a lecture introducing the Christie Foundation and its role in providing diagnostic and chemotherapy services for cancer patients, conducting scientific research, involving patients in their treatment, and improving their experience to achieve the highest satisfaction rates.

Joint studies between the Egypt Healthcare Authority, NHS, and the Christie Foundation included assessments of the readiness of healthcare facilities within the authority, and the Ismailia Medical Complex was selected to implement the first phase of the comprehensive cancer care centers project